Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renaissance IPO ETF (NY: IPO )

33.33 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Nov 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Renaissance IPO ETF

< Previous 1 2 3 4 5 Next >
Instructure Holdings Raises $250M Via IPO At $20 Per Share, Trading Begins Today
Education technology company Instructure Holdings Inc (NYSE: INST) priced 12.5 million shares at $20 per share in its initial public offering. It earlier... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Zenvia Raises $150M Via IPO At $13 Per Share
Customer experience communications platform Zenvia Inc (NASDAQ: ZENV) priced 11.5 million shares at $13 per share in its initial public offering. The... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
VTEX Raised $264M Via IPO At $19 Per Share, Trading Begins Today
Software-as-a-service digital commerce platform provider VTEX (NYSE: VTEX) priced 19 million shares at $19 per share in its initial public offering. The... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Paycor HCM Raised $425.5M Via IPO At $23 Per Share, Trading Begins Today
Human Capital Management (HCM) software creator Paycor HCM Inc (NASDAQ: PYCR) priced 18.5 million shares at $23 per share in its initial public offering. The... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Nervous System Firm Eliem Therapeutics Files For $80M IPO
Eliem Therapeutics (NASDAQ: ELYM), a Phase 2a biotech developing therapies for neuronal excitability disorders, filed an IPO prospectus with the SEC to raise up to $80... 
Via Benzinga
Topics Initial Public Offering Regulatory Compliance
Exposures Legal Regulatory Securities Market
Skin-Disease Focused Biotech Castle Creek Files $100M IPO
Ahead of Phase 3 data readout in the second half of next year, Castle Creek Biosciences Inc (NASDAQ: CCBS) seeks to make NASDAQ debut under the symbol CCBS. The Company... 
Via Benzinga
Adagio Files $100M IPO To Take Its COVID-19 Antibody Through Commercialization In 2022
Adagio Therapeutics has filed an initial public offering to raise money to bring its COVID-19 antibody to market. The $100 million IPO will support Phase 2/3 trials... 
Via Benzinga
Topics Initial Public Offering
Exposures COVID-19 Securities Market
Celularity Closes SPAC Merger With GX Acquisition, Trading Starts Monday
Celularity Inc has closed the merger with GX Acquisition Corp (NASDAQ: GXGX), giving Celularity $138 million to push the NK cell and T cell therapies into early-... 
Via Benzinga
Alibaba, SoftBank Backed Indian Online Payment Startup Paytm Eyes $2.2B IPO: TechCrunch
Indian digital payments startup, Paytm, plans to raise $2.2 billion in an initial public offering, TechCrunch reports. Alibaba Group Holding Ltd (NYSE: BABA) and Ant... 
Via Benzinga
Heart Disease Company Tenaya Therapeutics Files For $100M US IPO
Tenaya Therapeutics (NASDAQ: TNYA) is quickstepping into a $100 million NASDAQ debut under the TNYA symbol. The company filed an SEC prospectus on Friday. The biotech... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Ocular Medical Device Firm Sight Sciences Sets Terms For $150M IPO
Ophthalmic device developer Sight Sciences (NASDAQ: SGHT) hopes to see its way to nearly a $1 billion valuation through a $150 million Nasdaq debut. The IPO includes 7... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Precision Oncology-Focused Biotech Nuvalent Files For $100M IPO
Less than six months after emerging from stealth, the Deerfield-backed biotech Nuvalent (NASDAQ: NUVL) is already prepping a Nasdaq debut. Nuvalent filed its S-1... 
Via Benzinga
Rare Disease Biotech Rallybio Targets $100M IPO
Rallybio Corporation (NASDAQ: RLYB) ended the first quarter with nearly $128 million in the bank, and now it has filed to raise up to $100 million in its IPO to... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
GIC-Backed WCG Clinical Plans $100M NASDAQ Debut
WCG Clinical Inc (NASDAQ: WCGC), a clinical trial solutions company backed by Singapore's sovereign wealth fund GIC, filed for an initial public offering in the U.S. on... 
Via Benzinga
Caribou Biosciences Eyes $100M NASDAQ Debut To Propel Off-The-Shelf CAR-T Therapies In Blood Cancer
In a filing with SEC on Thursday, Caribou Biosciences (NASDAQ: CRBU) is penciling in a $100 million initial public offering. The firm expects that its new shares... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Intapp Prices IPO At $26 Per Share; Trading Begins Today
Cloud-based software solutions provider Intapp Inc (NASDAQ: INTA) priced 10.5 million shares at $26 per share in its initial public offering. The estimated gross... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
SoftBank-Backed Dingdong Downsizes U.S. IPO Target Following Missfresh Debacle: Reuters
SoftBank Group Corp (OTC: SFTBY) (OTC: SFTBF) Vision Fund II backed Chinese grocery app, Dingdong has downsized its U.S. initial public offering size to almost 25% of its... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Warehouse Robotics Company AutoStore Targets $10B IPO: Bloomberg
Norwegian warehouse robotics company, AutoStore, is exploring an initial public offering that could value it over $10 billion, Bloomberg reported. It is working with Morgan... 
Via Benzinga
Singapore's Online Marketplace Company Carousell Aims US Listing Via SPAC Merger: Bloomberg
Singapore’s online classifieds marketplace operator Carousell Pte is eyeing a U.S. listing via special purpose acquisition company (SPAC) merger at a valuation of... 
Via Benzinga
Sickle Cell Biotech, Graphite Bio Prices Upsized Initial Public Offering
Graphite Bio Inc (NASDAQ: GRPH) is set to go public on the heels of a $238 million raise less than ten months after getting started with a Series A funding of... 
Via Benzinga
Alzheimer's Biotech Acumen Pharmaceuticals Prices $125M IPO Soon After Biogen's Aduhelm Approval
Acumen Pharmaceuticals Inc has set the terms for its IPO to raise around $125 million to take ACU193, an antibody against amyloid-beta oligomers, to the end of phase 2 in... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Investors Face New Risks In Stock Market Forecast For The Next Six Months
Stocks are at a crossroads, with new risks taking shape even as the market hits new highs. 
Via Investor's Business Daily
Topics Economy
Exposures COVID-19 Economy
HealthCare Platform Doximity Prices Upsized IPO At $26/Share; Trading Begins Today
Doximity, Inc (NYSE: DOCS) priced 23.3 million shares at $26 per share in its initial public offering, for estimated gross proceeds are $494.3 million. The... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Hong Kong's Logistics Firm Lalamove Files Privately For $1B US IPO
Hong Kong’s on-demand logistics and delivery firm, Lalamove, or Huolala, has filed confidentially for a U.S. initial public offering (IPO) to raise a minimum of $1 billion... 
Via Benzinga
LegalZoom Aims To Raise $516M At $5B Valuation In Second US IPO Attempt: Reuters
Online legal services provider, LegalZoom, plans to sell over 19 million shares priced between $24 - $27 per share to raise $516 million at the top end of the range in its U.S.... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Software Database Firm Couchbase Files For US IPO: Reuters
Database software firm Couchbase Inc registered for a U.S. initial public offering (IPO) to tap the remote work fueled demand for data storage and processing, Reuters... 
Via Benzinga
Daniel Loeb-Backed SentinelOne Targets US IPO At Over $7B Valuation: Reuters
Billionaire investor Daniel Loeb's hedge fund, Third Point-backed cybersecurity firm SentinelOne Inc is aiming for a valuation of over $7 billion in its U.S.... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Peter Thiel-Backed Psychedelic Firm Atai Sets Terms For US IPO, Sees $2.3B Valuation
Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, has announced terms for its initial public offer... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
China's Uber, Didi Chuxing Could Command Valuation Over $70B Based On IPO Documents: WSJ
Uber Technologies Inc’s (NYSE: UBER) Chinese counterpart, Didi Chuxing Technology Co, could fetch a valuation of over $70 billion, the Wall Street Journal... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Why Shares of UiPath Were Up 10.9% in May
The software company saw a boost from the rising stock prices of recent IPOs. 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.